Baxalta

ADYNOVATE

  1. Home
  2.  / 
  3. J Code
  4.  / ADYNOVATE – J7207

Manufacturer:

Baxalta

Name:

ADYNOVATE

HCPCS Code Descriptor:

Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.

Category:

J Code

HCPCS:

J7207

NDC(s):

00944-4627-01, 00944-4628-01, 00944-4626-01, 00944-4625-01, 00944-4624-01, 00944-4622-01, 00944-4623-01

Primary Type:

Hematology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ADYNOVATE is a Hematology drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J7207 is aligned to the drug ADYNOVATE.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/17

HCPCS Effective Date:

1/1/17

HCPCS Short Description:

Factor viii pegylated recomb

Billing and Coding Guide:

https://www.shirecontent.com/PDFs/adynovate/ADYNOVATE-Quick-Reference-Coding-Sheet-Digital-R.pdf

Patient Assistance:

https://www.hematologysupport.com/financial-assistance#about-pap